Energizer Q3 Earnings & Sales Beat Estimates, Organic Sales Up Y/Y
ENR tops Q3 estimates with strong margin gains, boosted by Project Momentum, production credits and higher EPS guidance.
Newsbot
4 Value Stocks to Shield Amid Labor Market and Trade Worries
CVS, ITGR, ASB and FNB emerge as value picks amid trade tensions and labor market concerns, thanks to strong cash flow metrics.
Company News for Aug 4, 2025
Companies in The News Are: ENB,D,KMB,CHD
TTM Technologies Beats Q2 Earnings Estimates, Shares Fall on Weak View
TTMI slides 11% post earnings despite strong Q2 results, as investors react to soft Q3 guidance and a sequential revenue dip.
Murphy USA Q2 Earnings Top as Fuel Margins Improve, Sales Miss
MUSA tops Q2 earnings on stronger fuel margins, but weak petroleum sales drag total revenues below estimates.
Performant Healthcare (PHLT) Surges 115.2%: Is This an Indication of Further Gains?
Performant Healthcare (PHLT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Buy Mid-Cap AI Stock FIVN on Solid Q2 Earnings, Outlook & Valuation
FIVN posts record Q2 revenue, boosts AI growth, and trades at a steep valuation discount, making it a mid-cap AI standout.
Huntsmans Earnings and Revenues Lag Estimates in Q2, Down Y/Y
HUN posts wider-than-expected Q2 loss and lower revenues, hit by weak construction and industrial demand and reduced prices.
Will Healthy Top-Line Growth Benefit Motorolas Q2 Earnings?
MSIs Q2 results may reflect solid top-line growth, fueled by rising demand for mission-critical tech and new product rollouts.
ON Semiconductor Corp. (ON) Q2 Earnings Miss Estimates
ON Semiconductor Corp. (ON) delivered earnings and revenue surprises of -1.85% and +1.30%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Beat the Market the Zacks Way: Oracle, Credo Tech, Palantir in Focus
Oracle, Credo Tech, and Palantir shine in volatile markets, leading Zacks portfolios with standout gains and upgraded outlooks.
Should You Buy, Hold or Sell ATRO Stock Ahead of Q2 Earnings Release?
ATRO forecasts strong Q2 growth, but high leverage and soft Test Systems outlook may way on investor sentiment.
Can Higher Revenues Benefit Akamai This Earnings Season?
AKAMs Q2 revenue is likely to have risen on strong security and compute demand, but EPS may have dipped despite robust product launches.
J&J Expects Better Top-Line Growth in 2H: Can It Achieve the Goal?
JNJ lifts 2025 sales and EPS outlook on strong Q2 results, with new drug launches and MedTech gains fueling momentum.
These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Meta Platforms and Elevance Health have been highlighted as Zacks Bull and Bear of the Day
Meta earns Bull of the Day honors after a robust quarter, while Elevance Health tumbles on weak results and a steep EPS cut.
Should You Buy, Sell or Hold Lilly Stock Ahead of Q2 Earnings?
LLY eyes Q2 growth on Mounjaro and Zepbound momentum, but pricing pressure and rising competition test its edge.
DENTSPLY SIRONA to Post Q2 Earnings: Whats in Store for the Stock?
XRAYs Imaging strength and SureSmile growth might have lifted Q2 performance, but Bytes drag and macro pressures likely clouded the top-line momentum.
Agnico Eagles Q2 Earnings Beat Estimates on Higher Gold Prices
AEM beats Q2 earnings and revenue estimates as surging gold prices offset lower production and higher costs.
Aurora Cannabis Pre-Q1 Earnings Analysis: Buy, Sell or Hold the Stock?
ACBs global medical cannabis momentum stays strong, but near-term regulatory headwinds might have limited Q1 revenue upside.
Zimmer Biomet to Report Q2 Earnings: Heres What to Expect
ZBHs Q2 results may show strength in Hips, Knees, and S.E.T. despite a projected year-over-year earnings dip.
Cenovus Energy Q2 Earnings Beat Estimates, Revenues Miss
CVE tops Q2 EPS estimates with cost cuts but posts revenue decline and weaker segment contributions.
Twist Bioscience (TWST) Reports Q3 Loss, Tops Revenue Estimates
Twist Bioscience (TWST) delivered earnings and revenue surprises of +12.96% and +0.60%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
How Did Skyrizi and Rinvoq Sales Contribute to AbbVies Q2 Results?
AbbVies Q2 results show Skyrizi and Rinvoq powering growth, offsetting Humira declines and lifting 2025 sales outlook.
Canadian Natural to Report Q2 Earnings: Whats in the Offing?
CNQ is expected to see a boost in second-quarter results from favorable gas prices and new assets. Tariffs and rising costs are likely to have affected margins.
Cheniere Energy to Report Q2 Earnings: Whats in the Offing?
LNGs second-quarter revenues are likely to have been driven by rising LNG volumes. However, earnings are expected to have been impacted due to increasing costs.
Best Income Stocks to Buy for August 4th
NYMT, TRTX and FCF made it to the Zacks Rank #1 (Strong Buy) income stocks list on August 4, 2025.
Navigating the Robotaxi Revolution: Uber, Lyft, EPS Preview
Uber and Lyft will each report earnings this week. Investors will be focused on how each company is navigating the emergence of robotaxi vehicles.
New Strong Buy Stocks for August 4th
CLS, SBFG, HTB, HLI and UDMY have been added to the Zacks Rank #1 (Strong Buy) List on August 4, 2025.
Bull of the Day: Meta Platforms (META)
META continues to attract a growing number of users to its family of apps, resulting in consistently strong quarterly releases over recent periods. Can anything slow down the Mag 7 member?
Bear of the Day: Elevance Health (ELV)
A big guidance cut paints a challenging picture for the companys shares in the near term.
LNC Q2 Earnings Beat Estimates on Rising Insurance Premiums
Lincoln National beats Q2 estimates with a 28% EPS jump, fueled by rising premiums, strong deposits and lower expenses.
4 Utility Stocks Poised to Outperform in the Upcoming Earnings Cycle
Here are four utility stocks that are expected to post an earnings beat this reporting cycle.
Defensive ETFs to Gain Attention Amid Soft Jobs Data?
Weaker July jobs data and sharp revisions fuel rate cut bets and shine a light on five defensive ETFs like QQLV.
Top-Performing ETF Areas of July
Ethereum ETFs like QETH and CETH soared over 30% in July, fueled by bullish sentiment, policy moves and staking buzz.
Should You Buy, Sell, or Hold Innodata Stock Before Q2 Earnings? (Revised)
INODs second-quarter performance is expected to have benefited from Gen AI momentum and key customer expansion.
Innodata Trades 29% Below 52-Week High: Buy, Sell, or Hold the Stock? (Revised)
INOD rides Gen AI momentum with major Big Tech deals and a 40% revenue growth forecast, but high valuation raises caution.
Utilities ETF (XLU) Hits New 52-Week High
XLU surged to a 52-week high, gaining 21.5% from its low, as investor demand for defensive plays heats up.
HIMS & HERS HEALTH, INC. (NYSE: HIMS) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Hims & Hers Health, Inc. Investors of Upcoming Deadline
HIMS & HERS HEALTH, INC. (NYSE: HIMS) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Hims & Hers Health, Inc. Investors of Upcoming Deadline...
Interview waiver, dropbox shortcuts for nonimmigrant visa applicants are going away
On July 25, the U.S. Department of State announced that, effective September 2, most nonimmigrant visa applicants will no longer qualify for a visa interview waiver. Additionally, India’s popular...
An August Trading Lull? Global Week Ahead
After the nonfarm payroll print, this week looks fairly quiet on the macro data front. It is the summer holiday period of August in the Western Hemisphere.
B2Gold Set to Report Q2 Earnings: Whats in Store for the Stock?
BTGs Q2 earnings are likely to have surged on higher gold prices and output, though rising costs are expected to have pressured margins.
Rockwell Automation Stock Set to Report Q3 Earnings: What to Expect?
ROKs Q3 results may show margin strain and soft demand, but pricing actions could help offset earnings pressure.
McDonalds Stock Before Q2 Earnings: Buy Now or Wait for Results?
MCDs Q2 results are due on Aug. 6, with strong digital growth and menu innovation likely driving top-line gains.
Symbiotic Set to Report Q3 Earnings: Buy, Sell or Hold the Stock?
SYM gears up to report third-quarter fiscal 2025 earnings with rising revenues, soaring stock and strong backlog. Read on to find out whether you should buy, sell or hold.
Diageo to Report FY25 Results: What Surprise Awaits Investors?
DEO leans on premiumization and pricing power to drive growth, even as volumes soften across key markets.
Can B2Golds Fekola Expansion Fuel Long-Term Growth in Mali?
BTG gains Malis approval to begin underground mining at Fekola, setting the stage for major gold output expansion in 2025 and beyond.
Corpay Gears Up to Report Q2 Earnings: Whats in the Offing?
CPAY eyes second-quarter 2025 growth with gains across all segments, led by strong corporate payments and a solid margin performance.
Pan American Silver Gears Up to Report Q2 Earnings: What to Expect?
PAAS heads into Q2 earnings with a 264% expected EPS jump, driven by higher silver output, lower costs and rising metal prices.
Coeur Mining Gears Up to Report Q2 Earnings: What to Expect?
CDE set to post 114% sales surge and swing to profit in Q2 2025, fueled by strong output, pricing and Las Chispas gains.
Annaly Beats Q2 Earnings Estimates as Net Interest Income Rises Y/Y
NLY tops Q2 earnings estimates as net interest income jumps significantly year over year on increased loan demand.
Can Fidelity National Beat Q2 Earnings on Capital Market Strength?
FIS is likely to beat second-quarter earnings forecasts, driven by strength in Capital Market and Banking Solutions operations.
Copa Holdings Stock to Report Q2 Earnings: Whats in the Cards?
Lets assess the factors that are likely to have influenced CPAs second-quarter performance.
Should You Buy, Sell or Hold Shopify Stock Before Q2 Earnings?
SHOPs second-quarter 2025 performance is expected to reflect benefits from the growing adoption of merchant-friendly solutions.
Yum China Gears Up for Q2 Earnings: Key Factors to Note
YUMC eyes Q2 growth with 3.9% revenue gain and improved margins, but no clear signal of earnings beat just yet.
MGIC Investment Shares Gain 2.3% as Q2 Earnings Top Estimates
MTG beats Q2 EPS estimates by 17.1% as new insurance written jumps 21.5% and net premiums rise year over year.
Recursion Pharmaceuticals to Report Q2 Earnings: Whats in the Cards?
RXRX eyes Q2 earnings beat despite past misses, with a refocused pipeline and new data updates on key drug candidates.
Earnings Estimates Rising for Alnylam (ALNY): Will It Gain?
Alnylam Pharmaceuticals (ALNY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Radian Group Q2 Earnings Top Estimates, Premiums Decline Y/Y
RDN posts Q2 EPS of $1.01, beating estimates by 8.6%, as MI new insurance written rises 2.9% to $14.3B.
DoorDash Set to Report Q2 Earnings: Whats in Store for the Stock?
DASHs second-quarter 2025 results are likely to benefit from strong total orders and Marketplace GOV.
AT&T Surges 46.8% in a Year: Should T Stock Be in Your Portfolio?
With 243K fiber adds in the second quarter and a 46.8% surge, T is charging ahead, yet market saturation and stiff competition could test its momentum.
Will AMD Stock Climb on Strong Data Center Revenues in Q2 Earnings?
Advanced Micro Devices second-quarter 2025 earnings are likely to benefit from strong client and data center growth amid weakness in the Embedded segment.
Best Growth Stocks to Buy for August 4th
PRIM, AFYA and JBL made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 4, 2025.
Pagaya Q2 Earnings on the Cards: A Smart Buy or Risky Bet?
PGY expects strong Q2 results, with revenues anticipated to rise 29% year over year.
Buy, Sell or Hold Astera Labs Stock? Key Tips Ahead of Q2 Earnings
ALABs second-quarter 2025 results are likely to benefit from a strong portfolio amid stiff competition and tariff uncertainties.
Is MRVL Stock a Buy, Sell or Hold at a P/E Multiple of 7.15X?
Marvell Technologys AI-driven chip business surges, but margin pressure and China risks weigh on investor sentiment.
Should You Hold or Sell TOST Stock Before Q2 Earnings Release?
Toast eyes record Q2 net adds, but falling GPV per location and stretched valuation remain concerns.
TPC to Report Q2 Earnings: Buy or Sell This Construction Stock?
Tutor Perini Q2 earnings may rise on infrastructure strength, but margin headwinds and Building segment weakness cloud the outlook.
AVTR Stock Declines as Q2 Earnings Miss Estimates, Revenues Down Y/Y
Avantor stock dips more than 15% as Q2 EPS missed estimates, revenue declines year over year and lowers full-year guidance.
ICF International Stock Rises 5.4% Since Q2 Earnings Beat
ICFI beats on Q2 earnings but misses revenues as federal government contracts shrink. Shares rally 5.4% post-earnings.
Church & Dwight Q2 Earnings Beat Estimates, Volumes Fuel Organic Sales
CHD posts earnings beat in second-quarter 2025. Net sales dip 0.3% year over year on negative pricing and mix.
Should You Buy, Sell, or Hold SkyWater Stock Before Q2 Earnings?
SKYTs second-quarter 2025 results are likely to benefit from a strong demand for ThermaView amid weakness in the Advanced Technology Services business.
Novo Nordisk Before Q2 Earnings: How Should Investors Play the Stock?
NVOs second-quarter revenues are expected to have been driven by its sales of diabetes and obesity care products, Wegovy, Ozempic and Rybelsus.
4 Auto Stocks Likely to Outperform Q2 Earnings Estimates
CMI, RIVN, LCID, and AXL are poised to beat Q2 estimates despite industry headwinds and weaker sector earnings.
Utilities Witness Longest Win Streak Since 2009: ETFs to Play
Utilities ETFs like UTES, FXU and FUTY soared in July as the sector recorded its strongest streak since 2009.
Hims & Hers Health, Inc. (HIMS) - Lawmakers Urge Crackdown On Illegal Weight Loss Drugs, Novo’s Termination of Collaboration With HIMS Triggers Securities Class Actions -- Hagens Berman
HIMS Investors with Losses Encouraged to Contact Hagens Berman...